Immunotherapy in refractory epilepsy
PDF (Español)

Keywords

infection
virus
brain
diagnosis.

Abstract

This paper reviews the use of immunoglobulin and adrenocorticotropic hormone in the management of refractory epilepsy, as alternative therapies for these patients.

This application is clearly supported by physiopathology, the inflammatory phenomena associated to epilepsy are clearly known, they act by blocking inhibitory mechanisms and allowing for neuronal excitation. There are comprehensive descriptions about the successful use of immunoglobulin in disorders such as Rasmüssen’s encephalitis, Lennox-Gastaut syndrome, Landau-Kleffner syndrome and epilepsy with variable foci, and it has been also used as rescue treatment in West syndrome.

It is the treatment of choice in the United States, and there is no statistical difference in effectiveness in this syndrome when compared with vigabatrin.

In order to use these treatments, intercurrent infections should be ruled out and it is necessary to monitor closely its use to prevent complications.


PDF (Español)

References

- Aikoh H, Sasaki M, Sugai K, Yoshida H, Sakuragawa N. Case Report: Effective immunoglobulin therapy for brief tonic seizures in Methylmalonic acidemia. Brain & Development 1997; 19: 502-505.

- Best CH, Taylor. El Sistema de Control Hipotálamo

- hipofisiario. En: Bases fisiológicas de la Práctica Médica, cap. 52, 11ª edición. West JB. ed. Baltimore Williams and Wilkins, 1986: 1031- 1044.

- Billiau A, Witters P, Ceulemans B, Kasran A, Wouters C, Lagae L. Intravenous Immunoglobulins in Refractory Childhood-onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile. Epilepsia 2007; 48:1739-1749.

- Feasby T, Banwell B, Benstead T, et al. Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions. Transfusion Medicine Reviews 2007; 21 Suppl 1: pp S57-S107.

- Gallagher S, Weiss S, Oram Cardy J, Humphries T, Harman K, Menascu S. Efficacy of very high dose steroid treatment in a case of Landau-Kleffner Syndrome. Developmental Medicine & Child Neurology 2006; 48: 766-769.

- Granata T, Fusco L, Gobbi G, et al. Experience With Immunomodulatory Treatments In Rasmussen’s Encephalitis. Neurology 2003; 61:1807-1810.

- Gupta R, Appleton R. Corticosteroids Inin Thethe Management Ofof Thethe Paediatric Epilepsies. Arch Dis Child 2005;90: 379-384.

- Kivito S, Lerman R, Ariel R, Danziger Y, Mimouni M, Shinnar S. Long-Term Cognitive Outcomes of a Cohort of Children Withwith Cryptogenic Infantile Spasms Treated with High Dose of Adrenocorticotrophic Hormone. Epilepsia 2004; 45: 255-262.

- Mackay M, S, Weiss S, Adams-Webber T, et al. Medical Treatment of Infantile Spasms Report of the American Academy of Neurology and the Child Neurology Society. Neurologyy 2004; 62:1668-1681.

- McKnight K, Jiang Y, Hart Y et al. Serum Antibodies in Epilepsy and Seizure-Associated Disorders. Neurology, 2005; 65:1730-1736.

- Medina Malo, C; Arango, G; Carreño, O; Uscátegui, A. Etiología de la Epilepsia. En: Epilepsia: Aspectos Clínicos y Psicosociales. C. Medina Malo, ed. Bogotá: Editorial Médica Panamericana, 2004: 90-109.

- Oguni, H, Funatsuka M, Sasaki K et al. Effect of ACTH Therapy for Epileptic Spasms without Hipsarritmia. Epilepsia 2005; 46:709-715.

- Oguni H, Yanagaki S, Hayashi K et al. extremely low-dose ACTH step-up protocol for West syndrome: Maximum therapeutic effect with minimal side effects. Brain & Development 2006; 28: 8-13.

- Riikonen, R.S. Steroids or Vigabatrin in the Treatment of Infantile Spasms? Pediatr Neurol 2000; 23:403-408.

- Roubertie A, Boukhaddaoui H, Sieso V et al. Antiglial Cell Autoantibodies and Childhood Epilepsy: A Case Report. Epilepsia 2005; 46:1308-1312.

- Shinoda S, Skradski S, Araki T et al. Formation Of A Tumor Necrosis Factor Receptor 1 Molecular Scaffolding Complex And Activation Of Apoptosis Signal-Regulating Kinase 1 During Seizure-Induced Neuronal Death. European Journal of Neuroscience 2003; 17: 2065-2076

- Sinclair D B. Prednisone therapy in pediatric epilepsy. Pediatr Neurol 2003; 28: 194-198.

- Takahashi Y, Mori H, Mishina M et al. Autoantibodies and Cell-mediated Autoimmunity to NMDA-type GluR?2 in Patients with Rasmussen’s Encephalitis and Chronic Progressive Epilepsia Partialis Continua. Epilepsia 2005; 46(Suppl. 5):152-158.

- Verhelst H, Boon P, Buyse G et al. Steroids in intractable childhood epilepsy: Clinical experience and review of the literature. Seizure 2005; 14: 412 - 421.

- Vezzani A, Granata T. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence. Epilepsia 2005; 46):1724-1743.

- Villani F, Avanzini G. The Use of Immunoglobulins in the Treatment of Human Epilepsy. Neurol Sci 2002;

:S33-S37.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.